Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain
Go back to Heron Therapeutics Receives Complete Response Letter for HTX-011 for the Management of Postoperative Pain| HERON THERAPEUTICS (NASDAQ: HRTX) | Delayed: 0.36 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.36 | 52 Week High | $31.32 | |||
| Open | $0.36 | 52 Week Low | $13.95 | |||
| Day High | $0.36 | P/E | N/A | |||
| Day Low | $0.36 | EPS | $-3.29 | |||
| Volume | 561 | |||||



